Generali Investments Cee, Investicni Spolecnost, A.S. Viatris Inc Transaction History
Generali Investments Cee, Investicni Spolecnost, A.S.
- $970 Billion
- Q4 2024
A detailed history of Generali Investments Cee, Investicni Spolecnost, A.S. transactions in Viatris Inc stock. As of the latest transaction made, Generali Investments Cee, Investicni Spolecnost, A.S. holds 279,743 shares of VTRS stock, worth $2.61 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
279,743Holding current value
$2.61 Million% of portfolio
0.36%Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,141Shares Held
988MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.33 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$866 Million0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$595 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$584 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$548 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...